Featured Research

from universities, journals, and other organizations

ADHD: Scientists discover brain's anti-distraction system

Date:
April 18, 2014
Source:
Simon Fraser University
Summary:
Psychologists have made a brain-related discovery that could revolutionize doctors' perception and treatment of attention-deficit disorders. This discovery opens up the possibility that environmental and/or genetic factors may hinder or suppress a specific brain activity that the researchers have identified as helping us prevent distraction.

Psychologists have made a brain-related discovery that could revolutionize doctors' perception and treatment of attention-deficit disorders.
Credit: Feng Yu / Fotolia

Two Simon Fraser University psychologists have made a brain-related discovery that could revolutionize doctors' perception and treatment of attention-deficit disorders.

This discovery opens up the possibility that environmental and/or genetic factors may hinder or suppress a specific brain activity that the researchers have identified as helping us prevent distraction.

The Journal of Neuroscience has just published a paper about the discovery by John McDonald, an associate professor of psychology and his doctoral student John Gaspar, who made the discovery during his master's thesis research.

This is the first study to reveal our brains rely on an active suppression mechanism to avoid being distracted by salient irrelevant information when we want to focus on a particular item or task.

McDonald, a Canada Research Chair in Cognitive Neuroscience, and other scientists first discovered the existence of the specific neural index of suppression in his lab in 2009. But, until now, little was known about how it helps us ignore visual distractions.

"This is an important discovery for neuroscientists and psychologists because most contemporary ideas of attention highlight brain processes that are involved in picking out relevant objects from the visual field. It's like finding Waldo in a Where's Waldo illustration," says Gaspar, the study's lead author.

"Our results show clearly that this is only one part of the equation and that active suppression of the irrelevant objects is another important part."

Given the proliferation of distracting consumer devices in our technology-driven, fast-paced society, the psychologists say their discovery could help scientists and health care professionals better treat individuals with distraction-related attentional deficits.

"Distraction is a leading cause of injury and death in driving and other high-stakes environments," notes McDonald, the study's senior author. "There are individual differences in the ability to deal with distraction. New electronic products are designed to grab attention. Suppressing such signals takes effort, and sometimes people can't seem to do it.

"Moreover, disorders associated with attention deficits, such as ADHD and schizophrenia, may turn out to be due to difficulties in suppressing irrelevant objects rather than difficulty selecting relevant ones."

The researchers are now turning their attention to understanding how we deal with distraction. They're looking at when and why we can't suppress potentially distracting objects, whether some of us are better at doing so and why that is the case.

"There's evidence that attentional abilities decline with age and that women are better than men at certain visual attentional tasks," says Gaspar, the study's first author.

The study was based on three experiments in which 47 students performed an attention-demanding visual search task. Their mean age was 21. The researchers studied their neural processes related to attention, distraction and suppression by recording electrical brain signals from sensors embedded in a cap they wore.


Story Source:

The above story is based on materials provided by Simon Fraser University. Note: Materials may be edited for content and length.


Journal Reference:

  1. J. M. Gaspar, J. J. McDonald. Suppression of Salient Objects Prevents Distraction in Visual Search. Journal of Neuroscience, 2014; 34 (16): 5658 DOI: 10.1523/JNEUROSCI.4161-13.2014

Cite This Page:

Simon Fraser University. "ADHD: Scientists discover brain's anti-distraction system." ScienceDaily. ScienceDaily, 18 April 2014. <www.sciencedaily.com/releases/2014/04/140418141244.htm>.
Simon Fraser University. (2014, April 18). ADHD: Scientists discover brain's anti-distraction system. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2014/04/140418141244.htm
Simon Fraser University. "ADHD: Scientists discover brain's anti-distraction system." ScienceDaily. www.sciencedaily.com/releases/2014/04/140418141244.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins